XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Assets    
Cash and due from banks $ 276,291 $ 251,541
Interest bearing deposits with banks 178,905 177,088
Investment securities:    
Held to maturity (fair value of $2,184,792 at June 30, 2019 and $2,034,943 at December 31, 2018) 2,168,236 2,068,246
Available for sale 1,679,350 1,749,544
Total investment securities 3,847,586 3,817,790
Loans held for sale, at fair value 36,641 35,155
Loans 25,802,162 25,035,469
Less: Allowance for loan losses (155,105) (151,859)
Net loans 25,647,057 24,883,610
Premises and equipment, net 312,627 341,630
Lease right of use assets 283,348  
Bank owned life insurance 442,343 439,602
Accrued interest receivable 99,065 95,296
Goodwill 1,084,665 1,084,665
Other intangible assets, net 70,585 76,990
Other assets 748,628 659,721
Total Assets 33,027,741 31,863,088
Deposits:    
Non-interest bearing 6,327,789 6,175,495
Interest bearing:    
Savings, NOW and money market 11,107,952 11,213,495
Time 7,338,188 7,063,984
Total deposits 24,773,929 24,452,974
Short-term borrowings 2,387,784 2,118,914
Long-term borrowings 1,800,182 1,654,268
Junior subordinated debentures issued to capital trusts 55,544 55,370
Lease liabilities 307,405 3,125
Accrued expenses and other liabilities 198,779 227,983
Total Liabilities 29,523,623 28,512,634
Shareholders’ Equity    
Common stock (no par value, authorized 450,000,000 shares; issued 332,101,525 shares at June 30, 2019 and 331,634,951 shares at December 31, 2018) 116,571 116,240
Surplus 2,804,059 2,796,499
Retained earnings 412,190 299,642
Accumulated other comprehensive loss (35,131) (69,431)
Treasury stock, at cost (313,376 common shares at June 30, 2019 and 203,734 common shares at December 31, 2018) (3,262) (2,187)
Total Shareholders’ Equity 3,504,118 3,350,454
Total Liabilities and Shareholders’ Equity 33,027,741 31,863,088
Series A    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares 111,590 111,590
Series B    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares $ 98,101 $ 98,101